Header Logo

Connection

Idoroenyi Amanam to Prospective Studies

Back to Details
This is a "connection" page, showing publications Idoroenyi Amanam has written about Prospective Studies.
Idoroenyi Amanam
Connection Strength
0.046
Prospective Studies
  1. Tocilizumab for Cytokine Release Syndrome Management After Haploidentical Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis. Transplant Cell Ther. 2023 08; 29(8):515.e1-515.e7.
    View in: PubMed
    Score: 0.046
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.